Selvita S.A. (WSE:SLV)

Selvita Revenue

Selvita had revenue of 84.65M PLN in the quarter ending June 30, 2026, a decrease of -10.92%. This brings the company's total for the last twelve months to 349.00M, down -6.66% year-over-year. In the year 2025, Selvita had annual revenue of 370.57M with 7.17% growth. That makes Selvita the 23,616th largest company in the world by revenue and 171st in Poland.

• Revenue (ttm): 349.00M
• Revenue Growth: -6.66%
• P/S Ratio: 0.84
• Revenue / Employee: 388.21K
• Employees: 899
• Market Cap: 295.16M

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Drug Discovery 265.32M 71.5%
• Drug Development 103.37M 27.9%
• Unallocated Revenues From The Sale of Administrative Services 1.31M 0.4%
• Unallocated Other Income 987.00K 0.3%

By Geography

Chart

• Other European Union (EU) Members 147.28M 40.4%
• USA 96.79M 26.6%
• Switzerland 55.71M 15.3%
• UK 35.25M 9.7%
• Poland 19.78M 5.4%
• Other Countries 9.66M 2.6%

Fiscal year ended Dec 31, 2025 See the full Selvita breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	370.57M	24.80M	7.17%
Dec 31, 2024	345.76M	-6.09M	-1.73%
Dec 31, 2023	351.85M	-12.70M	-3.48%
Dec 31, 2022	364.55M	48.83M	15.47%
Dec 31, 2021	315.73M	173.80M	122.46%
Dec 31, 2020	141.93M	-104.34B	-99.86%
Dec 31, 2019	104.48B	21.42B	25.78%
Dec 31, 2018	83.06B	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Sep 17, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue segment and geography data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Nov 3, 2026

Data Sources Report a data error